血液バッグ市場レポート：製品タイプ、用途、エンドユーザー、材料、容量、地域別、2025～2033年

血液バッグの世界市場規模は2024年に3億1,260万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに6億3,720万米ドルに達し、2025年から2033年にかけて7.38%の成長率（CAGR）を示すと予測しています。同市場は、輸血需要の増加、さまざまな技術の進歩、新興市場におけるヘルスケアインフラの拡大、厳格な規制遵守、献血に対する意識の高まりなどを背景に、緩やかな成長を遂げています。

血液バッグ市場動向：

輸血需要の増加

血液バッグ世界市場の主な促進要因は、輸血需要の増加です。世界のヘルスケアシステムの進歩に伴い、手術、外傷治療、がん治療などの医療行為をサポートする血液および血液成分の必要性が高まっています。さらに、がんや血液疾患などの慢性疾患の有病率の増加が、血液製剤の需要に寄与しています。高齢化人口の着実な増加も大きな要因です。高齢者はさまざまな病状で輸血を必要とすることが多く、血液バッグ市場の需要をさらに押し上げています。このような持続的な需要は、血液バッグメーカーにとって安定した市場を保証しています。

血液バッグ製造における著しい技術進歩

技術の進歩は、血液バッグの品質と安全性を著しく向上させています。PVCフリーやDEHPフリーの素材の使用などの素材の革新は、汚染のリスクを減らし、保存される血液成分の完全性を保証します。RFID追跡システムは、血液バンクの在庫管理を強化し、効率性とトレーサビリティを向上させる。さらに、血小板を豊富に含む血漿（PRP）バッグや白血球減少フィルターなど、特定の目的に特化した血液バッグの開発により、ヘルスケア提供者の進化するニーズに対応した製品ラインナップが拡充されています。このような技術の進歩が血液バッグ市場の成長を促進し、患者の安全性を高めています。

新興市場におけるヘルスケアインフラの成長

新興国ではヘルスケアインフラの大幅な拡大が見られ、医療施設や治療へのアクセシビリティの向上につながっています。このような拡大は、これらの地域における血液バッグに対する需要の高まりと関連しています。ヘルスケアサービスがより利用しやすく高度になるにつれて、手術、出産、救急医療に対する血液バッグのニーズが高まっています。特にアジア太平洋地域では、ヘルスケア分野の拡大により血液バッグ市場が大きく成長しています。これらの地域はヘルスケアシステムの改善に投資を続けているため、この動向は今後も続くと予想されます。血液バッグ市場の売上は、新興国におけるヘルスケアインフラの拡大により、成長が見込まれています。

規制遵守と品質保証

厳しい規制要件と品質基準が血液バッグ製造の進歩を後押ししています。世界中の規制機関は、血液製剤の安全性と品質を確保するために厳しいガイドラインを課しています。これらの規制を遵守するためには、製品設計と製造工程を改善するためのメーカーの継続的な研究開発努力が必要です。これらの基準を遵守することで、患者の安全が確保され、血液バッグ製造業者の評判と信用も維持されます。一貫して規制要件を満たし、それを上回ることができる企業は、市場競争において優位に立つことができます。血液バッグ市場の展望は、厳しい規制基準を満たすための製造の進歩によって、引き続き有望です。

認知度の向上と献血キャンペーン

血液バッグ市場を維持する上で、国民の意識向上キャンペーンや献血を奨励する取り組みが重要な役割を果たしています。これらのキャンペーンは、献血の重要性とその救命の可能性について一般の人々を教育します。意識が高まるにつれ、より多くの人々が自発的に献血を行うようになり、血液の安定供給と血液バッグの必要性に貢献しています。さらに、緊急時、自然災害、パンデミック時には、献血活動が増加することが多く、このような状況に効率的に対処するための強固な血液バッグ市場の重要性がさらに強調されます。

目次

第1章 序文

第2章 調査範囲と調査手法

• 調査の目的
• ステークホルダー
• データソース
  • 一次情報
  • 二次情報
• 市場推定
  • ボトムアップアプローチ
  • トップダウンアプローチ
• 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の血液バッグ市場

• 市場概要
• 市場実績
• COVID-19の影響
• 市場予測

第6章 市場内訳：製品タイプ別

• 1重血液バッグ
• 2重血液バッグ
• 3重血液バッグ
• 4重血液バッグ
• ペンタ血液バッグ

第7章 市場内訳：用途別

• 採血用バッグ
• 輸送用バッグ

第8章 市場内訳：エンドユーザー別

• 病院
• クリニック
• 外来手術センター
• 血液バンク
• その他

第9章 市場内訳：材料別

• ポリ塩化ビニル製血液バッグ
• ポリエチレンテレフタレート血液バッグ
• その他

第10章 市場内訳：容量別

• 100ml
• 150ml
• 250ml
• 300ml
• 350ml
• 400ml
• 450ml
• 500ml

第11章 市場内訳：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
• アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • シンガポール
  • その他
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他
• 中東・アフリカ
  • トルコ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • その他

第12章 SWOT分析

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

第15章 価格分析

• 主要価格指標
• 価格構造
• 価格動向

第16章 競合情勢

• 市場構造
• 主要企業
• 主要企業のプロファイル
  • AdvaCare Pharma
  • BL Life Sciences Pvt. Ltd
  • Demophorius Healthcare Ltd.
  • Fresenius SE & Co. KGaA
  • Grifols S.A.
  • Haemonetics Corporation
  • HLL Lifecare Limited
  • Innvol Medical India Limited
  • JMS Co. Ltd.
  • Kawasumi Laboratories Inc.
  • Maco Pharma International GmbH
  • Mitra Industries Pvt. Ltd.
  • Neomedic Limited
  • Poly Medicure Ltd.
  • Span Healthcare Private Limited
  • Suru International Private Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • The Metric Company
  • Troge Medical GmbH

List of Figures

• Figure 1: Global: Blood Bags Market: Major Drivers and Challenges
• Figure 2: Global: Blood Bags Market: Sales Value (in Million USD), 2019-2024
• Figure 3: Global: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 4: Global: Blood Bags Market: Breakup by Product Type (in %), 2024
• Figure 5: Global: Blood Bags Market: Breakup by Application (in %), 2024
• Figure 6: Global: Blood Bags Market: Breakup by End User (in %), 2024
• Figure 7: Global: Blood Bags Market: Breakup by Material (in %), 2024
• Figure 8: Global: Blood Bags Market: Breakup by Capacity (in %), 2024
• Figure 9: Global: Blood Bags Market: Breakup by Region (in %), 2024
• Figure 10: Global: Blood Bags (Single Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 11: Global: Blood Bags (Single Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 12: Global: Blood Bags (Double Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 13: Global: Blood Bags (Double Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 14: Global: Blood Bags (Triple Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 15: Global: Blood Bags (Triple Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 16: Global: Blood Bags (Quadruple Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 17: Global: Blood Bags (Quadruple Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 18: Global: Blood Bags (Penta Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 19: Global: Blood Bags (Penta Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 20: Global: Blood Bags (Collection Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 21: Global: Blood Bags (Collection Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 22: Global: Blood Bags (Transfer Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 23: Global: Blood Bags (Transfer Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 24: Global: Blood Bags (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 25: Global: Blood Bags (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 26: Global: Blood Bags (Clinics) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 27: Global: Blood Bags (Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 28: Global: Blood Bags (Ambulatory Surgical Centers) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 29: Global: Blood Bags (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 30: Global: Blood Bags (Blood Banks) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 31: Global: Blood Bags (Blood Banks) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 32: Global: Blood Bags (Other End-Users) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 33: Global: Blood Bags (Other End-Users) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 34: Global: Blood Bags (Poly Vinyl Chloride Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 35: Global: Blood Bags (Poly Vinyl Chloride Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 36: Global: Blood Bags (Polyethylene Terephthalate Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 37: Global: Blood Bags (Polyethylene Terephthalate Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 38: Global: Blood Bags (Other Materials) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 39: Global: Blood Bags (Other Materials) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 40: Global: Blood Bags (100ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 41: Global: Blood Bags (100ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 42: Global: Blood Bags (150ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 43: Global: Blood Bags (150ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 44: Global: Blood Bags (250ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 45: Global: Blood Bags (250ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 46: Global: Blood Bags (300ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 47: Global: Blood Bags (300ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 48: Global: Blood Bags (350ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 49: Global: Blood Bags (350ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 50: Global: Blood Bags (400ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 51: Global: Blood Bags (400ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 52: Global: Blood Bags (450ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 53: Global: Blood Bags (450ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 54: Global: Blood Bags (500ml Blood Bag) Market: Sales Value (in Million USD), 2019 & 2024
• Figure 55: Global: Blood Bags (500ml Blood Bag) Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 56: North America: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 57: North America: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 58: United States: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 59: United States: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 60: Canada: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 61: Canada: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 62: Europe: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 63: Europe: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 64: Germany: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 65: Germany: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 66: France: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 67: France: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 68: United Kingdom: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 69: United Kingdom: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 70: Italy: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 71: Italy: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 72: Spain: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 73: Spain: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 74: Russia: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 75: Russia: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 76: Others: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 77: Others: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 78: Asia Pacific: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 79: Asia Pacific: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 80: China: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 81: China: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 82: Japan: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 83: Japan: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 84: India: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 85: India: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 86: South Korea: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 87: South Korea: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 88: Australia: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 89: Australia: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 90: Singapore: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 91: Singapore: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 92: Others: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 93: Others: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 94: Latin America: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 95: Latin America: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 96: Brazil: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 97: Brazil: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 98: Mexico: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 99: Mexico: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 100: Argentina: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 101: Argentina: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 102: Others: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 103: Others: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 104: Middle East and Africa: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 105: Middle East and Africa: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 106: Turkey: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 107: Turkey: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 108: South Africa: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 109: South Africa: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 110: Saudi Arabia: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 111: Saudi Arabia: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 112: UAE: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 113: UAE: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 114: Others: Blood Bags Market: Sales Value (in Million USD), 2019 & 2024
• Figure 115: Others: Blood Bags Market Forecast: Sales Value (in Million USD), 2025-2033
• Figure 116: Global: Blood Bags Industry: SWOT Analysis
• Figure 117: Global: Blood Bags Industry: Value Chain Analysis
• Figure 118: Global: Blood Bags Industry: Porter's Five Forces Analysis

List of Tables

• Table 1: Global: Blood Bags Market: Key Industry Highlights, 2024 and 2033
• Table 2: Global: Blood Bags Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
• Table 3: Global: Blood Bags Market Forecast: Breakup by Application (in Million USD), 2025-2033
• Table 4: Global: Blood Bags Market Forecast: Breakup by End User (in Million USD), 2025-2033
• Table 5: Global: Blood Bags Market Forecast: Breakup by Material (in Million USD), 2025-2033
• Table 6: Global: Blood Bags Market Forecast: Breakup by Capacity (in Million USD), 2025-2033
• Table 7: Global: Blood Bags Market Forecast: Breakup by Region (in Million USD), 2025-2033
• Table 8: Global: Blood Bags Market: Competitive Structure
• Table 9: Global: Blood Bags Market: Key Players

The global blood bags market size reached USD 312.6 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 637.2 Million by 2033, exhibiting a growth rate (CAGR) of 7.38% during 2025-2033. The market is experiencing moderate growth driven by the rising demand for blood transfusions, various technological advancements, the expanding healthcare infrastructure in emerging markets, stringent regulatory compliance, and the growing awareness about blood donation.

Blood Bags Market Trends:

Increasing Demand for Blood Transfusions

The primary driver of the global blood bags market is the rising demand for blood transfusions. As healthcare systems worldwide continue to advance, there is a growing need for blood and blood components to support medical procedures such as surgeries, trauma care, and cancer treatments. Moreover, the increasing prevalence of chronic diseases, including cancer and blood disorders, contributes to the demand for blood products. The steady increase in the aging population is also a significant factor. Older individuals often require blood transfusions for various medical conditions, further propelling the blood bags market demand. This sustained demand ensures a stable market for blood bag manufacturers.

Significant Technological Advancements in Blood Bag Manufacturing

Technological advancements have significantly improved the quality and safety of blood bags. Innovations in materials, such as the use of PVC-free and DEHP-free materials, reduce the risk of contamination and ensure the integrity of stored blood components. RFID tracking systems enhance inventory management in blood banks, enhancing efficiency and traceability. Furthermore, the development of specialized blood bags for specific purposes, such as platelet-rich plasma (PRP) bags and leukocyte reduction filters, has expanded the product range, meeting the evolving needs of healthcare providers. These technological advancements drive blood bags market growth and enhance patient safety.

Growing Healthcare Infrastructure in Emerging Markets

Emerging economies are witnessing a significant expansion of their healthcare infrastructure, leading to increased accessibility to medical facilities and treatments. This expansion correlates with a rising demand for blood bags in these regions. As healthcare services become more accessible and advanced, the need for blood bags for surgeries, childbirth, and emergency care rises. The Asia-Pacific region, in particular, is experiencing substantial growth in its blood bags market due to its expanding healthcare sector. This trend is expected to continue as these regions continue to invest in improving their healthcare systems. The blood bags market revenue is poised for growth on account of the expanding healthcare infrastructure in emerging economies.

Regulatory Compliance and Quality Assurance

Stringent regulatory requirements and quality standards drive advancements in blood bag manufacturing. Regulatory bodies worldwide impose strict guidelines to ensure the safety and quality of blood products. Compliance with these regulations necessitates continuous research and development efforts by manufacturers to improve product design and manufacturing processes. Adherence to these standards ensures patient safety and also maintains the reputation and credibility of blood bag manufacturers. Companies that can consistently meet and exceed regulatory requirements gain a competitive edge in the market. The blood bags market outlook remains promising, driven by advancements in manufacturing to meet stringent regulatory standards.

Rising Awareness and Blood Donation Campaigns

Public awareness campaigns and initiatives to encourage blood donation have played a crucial role in sustaining the blood bags market. These campaigns educate the public about the importance of donating blood and its life-saving potential. As awareness increases, more individuals are likely to donate blood voluntarily, contributing to a steady supply of blood and the need for blood bags. Moreover, during emergencies, natural disasters, and pandemics, there is often a rise in blood donation drives, further emphasizing the significance of a robust blood bags market to handle these situations efficiently.

Blood Bags Industry Segmentation:

Breakup by Product Type:

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag

Single blood bag accounts for the majority of the market share

Single blood bags are a fundamental component of blood collection and storage. They are designed to hold a single unit of blood, making them essential for basic blood transfusions and blood donation centers. Single blood bags are easy to handle and ensure the safe storage and transport of blood and blood components, making them a cornerstone of the healthcare industry.

Double blood bags are designed to store and separate two units of blood or blood components within a single bag. This segmentation is particularly useful for blood banks and hospitals when dealing with multiple units of blood from donors or for specific medical procedures that require two types of blood components.

Triple blood bags are engineered to accommodate three distinct units of blood or blood products. This configuration is critical in cases where precise separation and storage of multiple blood components such as red blood cells, plasma, and platelets are needed. It enhances the efficiency of blood processing and distribution.

Quadruple blood bags are designed to hold four separate units of blood or blood components. They find extensive use in advanced medical treatments, such as organ transplantation and complex surgical procedures. These bags ensure the availability of different blood products when required.

Penta blood bags are the most comprehensive of the blood bag types, capable of storing five units of blood or blood components independently. They are indispensable for situations demanding a wide array of blood products, especially in trauma centers, where rapid access to various blood components can be life-saving.

Breakup by Application:

• Collection Blood Bag
• Transfer Blood Bag

Collection blood bag holds the largest share in the industry

The collection blood bag segment represents a critical component of the global blood bags market. Collection blood bags are specifically designed for the safe and efficient collection of blood from donors during blood donation drives or in clinical settings. These bags come equipped with features that ensure the preservation and integrity of the collected blood, preventing contamination and maintaining the viability of blood components. Collection blood bags typically include anticoagulants to prevent blood clotting, allowing for the separation of whole blood into its individual components such as, red blood cells, plasma, and platelets. These bags play a pivotal role in the blood supply chain, ensuring that the collected blood can be processed, tested, and stored for subsequent transfusions.

The transfer blood bag segment is another integral part of the global blood bags market. Transfer blood bags are designed for the safe and aseptic transfer of blood and its components within healthcare facilities, blood banks, and laboratories. They play a crucial role in maintaining the integrity of blood components during storage, transport, and transfusion. These bags are used to transfer blood from collection bags to storage bags or to administer blood to patients during transfusion. They are designed with features that minimize the risk of contamination and air entry, ensuring that the blood remains in optimal condition for medical procedures. In recent years, transfer blood bag manufacturers have focused on improving the safety and efficiency of blood transfusions. This includes innovations such as the integration of safety connectors to prevent accidental needlesticks, advanced port designs for smooth and airtight blood transfer, and tamper-evident seals to enhance product security.

Breakup by End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Blood Banks
• Others

Hospitals represents the leading market segment

Hospitals represent one of the largest and most critical segments in the global blood bags market. These healthcare facilities are major consumers of blood bags due to the diverse range of medical procedures they perform. Hospitals utilize blood bags for surgeries, trauma care, organ transplants, and the treatment of various medical conditions. The demand for blood bags in hospitals is directly related to the number of inpatient and outpatient procedures conducted, making it a steady and consistent market. Furthermore, as hospitals aim to provide high-quality patient care, they prioritize the use of technologically advanced blood bags to ensure the safety and integrity of blood and its components.

Clinics, including both general and specialized medical clinics, form another crucial segment in the blood bags market. These facilities often require blood bags for smaller-scale medical procedures, diagnostic tests, and treatments. Clinics play a significant role in preventive healthcare, and blood bags are essential for various clinical applications, such as blood testing, transfusions for chronic disease management, and minor surgical procedures. The demand for blood bags in clinics is driven by the need for rapid and convenient access to blood products for patient care.

Ambulatory surgical centers have gained prominence in recent years due to their ability to provide cost-effective, same-day surgical procedures. This segment of the market demands blood bags for surgeries and medical interventions that do not require extended hospitalization. ASCs prioritize efficient patient care, and the availability of high-quality blood bags is essential to support their surgical services. The growth of ASCs has contributed to the expansion of the blood bags market, particularly in outpatient surgical settings.

Blood banks are dedicated facilities responsible for collecting, processing, and storing donated blood. While they are not traditional end users in the sense of consuming blood bags, blood banks are a fundamental segment of the market. They require a constant supply of blood bags to manage the collection and distribution of blood and its components to hospitals and healthcare facilities. The efficiency and safety of blood bags are critical for blood banks to maintain a stable and reliable blood supply, making them a vital part of the overall market ecosystem.

Breakup by Material:

• Poly Vinyl Chloride Blood Bag
• Polyethylene Terephthalate Blood Bag
• Others

Poly vinyl chloride blood bag represents the leading market segment

Poly Vinyl Chloride (PVC) blood bags have historically been one of the primary materials used for blood collection and storage. These bags are known for their flexibility, durability, and cost-effectiveness. PVC blood bags are widely adopted in many healthcare settings due to their excellent compatibility with blood components and additives. PVC blood bags are preferred for their ability to maintain the quality and integrity of blood components over extended periods. They are particularly suitable for the storage of whole blood and red blood cells.

Polyethylene Terephthalate (PET) blood bags have gained prominence in the blood bags market due to their advantages in terms of safety and environmental impact. PET is a plastic material known for its excellent biocompatibility and resistance to plasticizer leaching, making it a safer choice for storing blood and its components. PET blood bags are preferred for their ability to maintain the quality of blood components while minimizing the risk of contamination. They are especially suitable for the storage of platelets and plasma due to their inert nature. Additionally, PET is considered an eco-friendly material as it is recyclable and less harmful to the environment compared to PVC.

Breakup by Capacity:

• 100ml Blood Bag
• 150ml Blood Bag
• 250ml Blood Bag
• 300ml Blood Bag
• 350ml Blood Bag
• 400ml Blood Bag
• 450ml Blood Bag
• 500ml Blood Bag

300ml blood bag represents the leading market segment

Blood bags with a 300ml capacity are often utilized in cases where a larger volume of blood or blood components is required, such as in major surgeries or to support patients with substantial blood loss. They offer increased transfusion efficiency and are essential for critical medical situations.

The 100ml blood bag segment serves a specific niche within the healthcare industry. These small-sized bags are typically used for pediatric patients, neonatal care, and specialized medical procedures where a smaller volume of blood is required. They are designed to minimize waste and ensure precise transfusions for the most vulnerable patients, including premature infants.

Blood bags with a capacity of 150ml are versatile and find extensive use in various medical scenarios. They are commonly employed for transfusions in children, small adults, and during specific medical procedures. Their intermediate size allows for flexibility in catering to different patient needs while minimizing the risk of over-transfusion.

The 250ml blood bag segment represents a standard size for adult blood transfusions. It is widely used in hospitals and blood banks for general medical procedures, surgeries, and trauma care. These bags strike a balance between capacity and ease of handling, making them a cornerstone of the blood bags market.

The 350ml blood bag segment caters to specific healthcare needs, especially in cases of massive blood loss or certain therapeutic procedures. These bags provide healthcare professionals with a larger volume to work with, ensuring adequate support for patients undergoing complex treatments.

Blood bags with a capacity of 400ml are essential in situations demanding a significant amount of blood, such as open-heart surgeries or organ transplant procedures. Their larger volume is crucial for maintaining patient stability during these high-risk operations.

The 450ml blood bag segment serves as a specialized solution for specific medical scenarios, often requiring larger transfusion volumes. These bags find application in procedures, such as autologous blood transfusions and treatments, for conditions requiring substantial blood replacement.

The 500ml blood bag segment represents the highest capacity within the market. These bags are used in critical situations where large quantities of blood or blood components are needed, such as in cases of severe trauma or extensive surgeries. They provide healthcare providers with the capability to respond effectively to life-threatening conditions.

Breakup by Region:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore
  • Others
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Others
• Middle East and Africa
  • Turkey
  • South Africa
  • Saudi Arabia
  • UAE
  • Others

North America leads the market, accounting for the largest blood bags market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Asia Pacific (China, Japan, India, South Korea, Australia, Singapore, and others); Latin America (Brazil, Mexico, Argentina, and others); and the Middle East and Africa (Turkey, South Africa, Saudi Arabia, UAE, and others). According to the report, North America accounted for the largest market share.

North America is a mature and significant market for blood bags. The region is characterized by well-established healthcare infrastructure, stringent regulatory standards, and a high demand for blood and blood components due to advanced medical procedures. The United States, in particular, is a major contributor to the North American market. Technological advancements, including the adoption of RFID tracking and safer materials, are common in this region. While the market here is relatively stable, there is a constant focus on improving safety and efficiency.

Europe is another prominent market for blood bags, with countries such as, Germany, France, and the United Kingdom leading the way. The European market benefits from a robust healthcare system and a consistent demand for blood products. Regulatory compliance is stringent, driving innovation and quality assurance. The market in Europe is also characterized by sustainability initiatives, with a growing emphasis on eco-friendly blood bag materials. Collaborations between manufacturers and healthcare institutions are common to ensure a stable supply of blood products.

The Asia-Pacific region is witnessing rapid growth in the blood bags market due to the expansion of healthcare infrastructure, increasing medical procedures, and a rising awareness about blood donation. Countries such as, China and India are key players in this region, driven by their large populations. Technological advancements, while present, are still evolving, offering opportunities for manufacturers to penetrate this market further. Additionally, the Asia-Pacific region is focusing on local production to reduce dependence on imports, contributing to market expansion.

The Middle East and Africa region experience a diverse market landscape. Some countries in the Middle East, such as, the United Arab Emirates and Saudi Arabia, have advanced healthcare systems with a strong demand for blood bags. In contrast, certain regions in Africa face challenges related to healthcare accessibility and infrastructure. Nevertheless, the market is growing as healthcare facilities improve, and awareness about blood donation increases. Manufacturers are exploring opportunities in this region, focusing on affordability and accessibility to capture emerging markets.

Leading Key Players in the Blood Bags Industry:

The key players in the market are actively engaging in various strategic initiatives to maintain their competitive edge and meet evolving market demands. These initiatives include continuous research and development efforts to improve blood bag materials and technologies, ensuring the safety and quality of blood products. Additionally, these companies are expanding their geographical footprint by establishing a strong presence in emerging markets, such as Asia-Pacific and Latin America, where demand is growing rapidly. Collaboration with healthcare institutions, adherence to stringent regulatory standards, and a focus on sustainability are also key priorities for these industry leaders.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

• AdvaCare Pharma
• BL Life Sciences Pvt. Ltd
• Demophorius Healthcare Ltd.
• Fresenius SE & Co. KGaA
• Grifols S.A.
• Haemonetics Corporation
• HLL Lifecare Limited
• Innvol Medical India Limited
• JMS Co. Ltd.
• Kawasumi Laboratories Inc.
• Maco Pharma International GmbH
• Mitra Industries Pvt. Ltd.
• Neomedic Limited
• Poly Medicure Ltd.
• Span Healthcare Private Limited
• Suru International Private Ltd.
• Teleflex Incorporated
• Terumo Corporation
• The Metric Company
• Troge Medical GmbH

Key Questions Answered in This Report

• 1.What was the size of the global blood bags market in 2024?
• 2.What is the expected growth rate of the global blood bags market during 2025-2033?
• 3.What are the key factors driving the global blood bags market?
• 4.What has been the impact of COVID-19 on the global blood bags market?
• 5.What is the breakup of the global blood bags market based on the product type?
• 6.What is the breakup of the global blood bags market based on the application?
• 7.What is the breakup of the global blood bags market based on the end user?
• 8.What is the breakup of the global blood bags market based on the material?
• 9.What is the breakup of the global blood bags market based on the capacity?
• 10.What are the key regions in the global blood bags market?
• 11.Who are the key players/companies in the global blood bags market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Blood Bags Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product Type

• 6.1 Single Blood Bag
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Double Blood Bag
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Triple Blood Bag
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Quadruple Blood Bag
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Penta Blood Bag
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast

7 Market Breakup by Application

• 7.1 Collection Blood Bag
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Transfer Blood Bag
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Blood Banks
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Material

• 9.1 Poly Vinyl Chloride Blood Bag
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Polyethylene Terephthalate Blood Bag
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Capacity

• 10.1 100ml Blood Bag
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 150ml Blood Bag
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 250ml Blood Bag
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 300ml Blood Bag
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 350ml Blood Bag
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast
• 10.6 400ml Blood Bag
  • 10.6.1 Market Trends
  • 10.6.2 Market Forecast
• 10.7 450ml Blood Bag
  • 10.7.1 Market Trends
  • 10.7.2 Market Forecast
• 10.8 500ml Blood Bag
  • 10.8.1 Market Trends
  • 10.8.2 Market Forecast

11 Market Breakup by Region

• 11.1 North America
  • 11.1.1 United States
    • 11.1.1.1 Market Trends
    • 11.1.1.2 Market Forecast
  • 11.1.2 Canada
    • 11.1.2.1 Market Trends
    • 11.1.2.2 Market Forecast
• 11.2 Europe
  • 11.2.1 Germany
    • 11.2.1.1 Market Trends
    • 11.2.1.2 Market Forecast
  • 11.2.2 France
    • 11.2.2.1 Market Trends
    • 11.2.2.2 Market Forecast
  • 11.2.3 United Kingdom
    • 11.2.3.1 Market Trends
    • 11.2.3.2 Market Forecast
  • 11.2.4 Italy
    • 11.2.4.1 Market Trends
    • 11.2.4.2 Market Forecast
  • 11.2.5 Spain
    • 11.2.5.1 Market Trends
    • 11.2.5.2 Market Forecast
  • 11.2.6 Russia
    • 11.2.6.1 Market Trends
    • 11.2.6.2 Market Forecast
  • 11.2.7 Others
    • 11.2.7.1 Market Trends
    • 11.2.7.2 Market Forecast
• 11.3 Asia Pacific
  • 11.3.1 China
    • 11.3.1.1 Market Trends
    • 11.3.1.2 Market Forecast
  • 11.3.2 Japan
    • 11.3.2.1 Market Trends
    • 11.3.2.2 Market Forecast
  • 11.3.3 India
    • 11.3.3.1 Market Trends
    • 11.3.3.2 Market Forecast
  • 11.3.4 South Korea
    • 11.3.4.1 Market Trends
    • 11.3.4.2 Market Forecast
  • 11.3.5 Australia
    • 11.3.5.1 Market Trends
    • 11.3.5.2 Market Forecast
  • 11.3.6 Singapore
    • 11.3.6.1 Market Trends
    • 11.3.6.2 Market Forecast
  • 11.3.7 Others
    • 11.3.7.1 Market Trends
    • 11.3.7.2 Market Forecast
• 11.4 Latin America
  • 11.4.1 Brazil
    • 11.4.1.1 Market Trends
    • 11.4.1.2 Market Forecast
  • 11.4.2 Mexico
    • 11.4.2.1 Market Trends
    • 11.4.2.2 Market Forecast
  • 11.4.3 Argentina
    • 11.4.3.1 Market Trends
    • 11.4.3.2 Market Forecast
  • 11.4.4 Others
    • 11.4.4.1 Market Trends
    • 11.4.4.2 Market Forecast
• 11.5 Middle East and Africa
  • 11.5.1 Turkey
    • 11.5.1.1 Market Trends
    • 11.5.1.2 Market Forecast
  • 11.5.2 South Africa
    • 11.5.2.1 Market Trends
    • 11.5.2.2 Market Forecast
  • 11.5.3 Saudi Arabia
    • 11.5.3.1 Market Trends
    • 11.5.3.2 Market Forecast
  • 11.5.4 UAE
    • 11.5.4.1 Market Trends
    • 11.5.4.2 Market Forecast
  • 11.5.5 Others
    • 11.5.5.1 Market Trends
    • 11.5.5.2 Market Forecast

12 SWOT Analysis

• 12.1 Overview
• 12.2 Strengths
• 12.3 Weaknesses
• 12.4 Opportunities
• 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

• 14.1 Overview
• 14.2 Bargaining Power of Buyers
• 14.3 Bargaining Power of Suppliers
• 14.4 Degree of Competition
• 14.5 Threat of New Entrants
• 14.6 Threat of Substitutes

15 Price Analysis

• 15.1 Key Price Indicators
• 15.2 Price Structure
• 15.3 Price Trends

16 Competitive Landscape

• 16.1 Market Structure
• 16.2 Key Players
• 16.3 Profiles of Key Players
  • 16.3.1 AdvaCare Pharma
    • 16.3.1.1 Company Overview
    • 16.3.1.2 Product Portfolio
  • 16.3.2 BL Life Sciences Pvt. Ltd
    • 16.3.2.1 Company Overview
    • 16.3.2.2 Product Portfolio
  • 16.3.3 Demophorius Healthcare Ltd.
    • 16.3.3.1 Company Overview
    • 16.3.3.2 Product Portfolio
  • 16.3.4 Fresenius SE & Co. KGaA
    • 16.3.4.1 Company Overview
    • 16.3.4.2 Product Portfolio
    • 16.3.4.3 Financials
    • 16.3.4.4 SWOT Analysis
  • 16.3.5 Grifols S.A.
    • 16.3.5.1 Company Overview
    • 16.3.5.2 Product Portfolio
    • 16.3.5.3 Financials
    • 16.3.5.4 SWOT Analysis
  • 16.3.6 Haemonetics Corporation
    • 16.3.6.1 Company Overview
    • 16.3.6.2 Product Portfolio
    • 16.3.6.3 Financials
    • 16.3.6.4 SWOT Analysis
  • 16.3.7 HLL Lifecare Limited
    • 16.3.7.1 Company Overview
    • 16.3.7.2 Product Portfolio
  • 16.3.8 Innvol Medical India Limited
    • 16.3.8.1 Company Overview
    • 16.3.8.2 Product Portfolio
  • 16.3.9 JMS Co. Ltd.
    • 16.3.9.1 Company Overview
    • 16.3.9.2 Product Portfolio
    • 16.3.9.3 Financials
  • 16.3.10 Kawasumi Laboratories Inc.
    • 16.3.10.1 Company Overview
    • 16.3.10.2 Product Portfolio
    • 16.3.10.3 Financials
  • 16.3.11 Maco Pharma International GmbH
    • 16.3.11.1 Company Overview
    • 16.3.11.2 Product Portfolio
  • 16.3.12 Mitra Industries Pvt. Ltd.
    • 16.3.12.1 Company Overview
    • 16.3.12.2 Product Portfolio
  • 16.3.13 Neomedic Limited
    • 16.3.13.1 Company Overview
    • 16.3.13.2 Product Portfolio
  • 16.3.14 Poly Medicure Ltd.
    • 16.3.14.1 Company Overview
    • 16.3.14.2 Product Portfolio
  • 16.3.15 Span Healthcare Private Limited
    • 16.3.15.1 Company Overview
    • 16.3.15.2 Product Portfolio
  • 16.3.16 Suru International Private Ltd.
    • 16.3.16.1 Company Overview
    • 16.3.16.2 Product Portfolio
  • 16.3.17 Teleflex Incorporated
    • 16.3.17.1 Company Overview
    • 16.3.17.2 Product Portfolio
    • 16.3.17.3 Financials
    • 16.3.17.4 SWOT Analysis
  • 16.3.18 Terumo Corporation
    • 16.3.18.1 Company Overview
    • 16.3.18.2 Product Portfolio
    • 16.3.18.3 Financials
    • 16.3.18.4 SWOT Analysis
  • 16.3.19 The Metric Company
    • 16.3.19.1 Company Overview
    • 16.3.19.2 Product Portfolio
  • 16.3.20 Troge Medical GmbH
    • 16.3.20.1 Company Overview
    • 16.3.20.2 Product Portfolio